Efficacy and safety of sintilimab in combination with lenvatinib therapy as second⁃line regimen for patients with unresectable hepatocellular carcinoma

WANG Junjie, XU Long, YUAN Guosheng, XU Xiaoming, ZHOU Xiaoyuan, LUO Runqi.
The Journal of Practical Medicine . 2022, (9): 1130 -1135 .  DOI: 10.3969/j.issn.1006⁃5725.2022.09.016